Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
6.623 / 17.032
#52978

Re: Farmas USA

ARNA

Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced top-line results from the Phase 2 trial investigating lorcaserin HCl, a serotonin 2C receptor agonist, for smoking cessation. The trial demonstrated statistically significant improvement over placebo in reducing the number of patients who smoke after 12 weeks of treatment. The detailed results of the trial are expected to be presented at a future scientific meeting.

http://boardvote.com/symbol/ARNA/communique/799937

#52979

Re: Farmas USA

Soy bastante desastre. Alguno me lo guardo como cosa temporal para tenerlo en cuenta y luego se quedan ahí junto con las cosas importantes.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#52980

Re: Farmas USA

Arena Pharmaceuticals beats by $0.07, misses on revenue • 6:56 AM

Mohit Manghnani, SA News Editor
  • Arena Pharmaceuticals (NASDAQ:ARNA): Q3 EPS of -$0.05 beats by $0.07.
  • Revenue of $8.2M (+129.1% Y/Y) misses by $2.67M.

http://seekingalpha.com/pr/11529015-arena-pharmaceuticals-provides-corporate-update-and-reports-third-quarter-2014-financial-results?app=n

 

 

Arena product revenues up 185%

Arena Pharmaceuticals (NASDAQ:ARNA) Q3 results ($M): 

Total Revenues: 8.2 (+128%);

Product Revenues: 5.7 (+185%);

Operating Expenses: 32.5 (45%);

Net Loss: (10.7) (+38%);

Loss Per Share: (0.05) (+38%);

Quick Assets: 188.3 (-15%).

Belviq prescriptions: 143,000;

Eisai Belviq revenues: $16.8M.

 

ARNA

#52984

Re: Farmas USA

ARNA atizando tras presentar resultados, que clasico.....

Te puede interesar...
  1. Inflación y tipos en el punto de mira, la historia no se repite pero rima
  2. La Euforia Post-Trump: ¿Calma o Tormenta en el Mercado?